Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
35 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Tolero Pharmaceuticals, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Tolero Pharmaceuticals, Inc. - Product Pipeline Review - 2016', provides an overview of the Tolero Pharmaceuticals, Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Tolero Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Tolero Pharmaceuticals, Inc. - The report provides overview of Tolero Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Tolero Pharmaceuticals, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Tolero Pharmaceuticals, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to Buy - Evaluate Tolero Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Tolero Pharmaceuticals, Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Tolero Pharmaceuticals, Inc.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Tolero Pharmaceuticals, Inc. Snapshot 5 Tolero Pharmaceuticals, Inc. Overview 5 Key Information 5 Key Facts 5 Tolero Pharmaceuticals, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Tolero Pharmaceuticals, Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Tolero Pharmaceuticals, Inc. - Pipeline Products Glance 11 Tolero Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Tolero Pharmaceuticals, Inc. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Tolero Pharmaceuticals, Inc. - Drug Profiles 13 alvocidib hydrochloride 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 HCI-1680 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 HCI-1708 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 SGI-7079 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 TP-0158 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 TP-0184 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 TP-0413 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 TP-0903 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 TP-1101 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 TP-3654 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Tolero Pharmaceuticals, Inc. - Pipeline Analysis 24 Tolero Pharmaceuticals, Inc. - Pipeline Products by Target 24 Tolero Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 25 Tolero Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 26 Tolero Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 27 Tolero Pharmaceuticals, Inc. - Recent Pipeline Updates 28 Tolero Pharmaceuticals, Inc. - Dormant Projects 31 Tolero Pharmaceuticals, Inc. - Discontinued Pipeline Products 32 Discontinued Pipeline Product Profiles 32 SGI-1776 32 Tolero Pharmaceuticals, Inc. - Locations And Subsidiaries 33 Head Office 33 Appendix 34 Methodology 34 Coverage 34 Secondary Research 34 Primary Research 34 Expert Panel Validation 34 Contact Us 34 Disclaimer 35
List of Tables Tolero Pharmaceuticals, Inc., Key Information 5 Tolero Pharmaceuticals, Inc., Key Facts 5 Tolero Pharmaceuticals, Inc. - Pipeline by Indication, 2016 7 Tolero Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016 9 Tolero Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016 10 Tolero Pharmaceuticals, Inc. - Phase II, 2016 11 Tolero Pharmaceuticals, Inc. - Preclinical, 2016 12 Tolero Pharmaceuticals, Inc. - Pipeline by Target, 2016 24 Tolero Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016 25 Tolero Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016 26 Tolero Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016 27 Tolero Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016 28 Tolero Pharmaceuticals, Inc. - Dormant Developmental Projects,2016 31 Tolero Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016 32
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.